Alkem MedTech to Acquire 55% Stake in Switzerland’s Occlutech Holding for $118 Million
Alkem Laboratories announced that its medical devices arm will acquire up to a 55% stake in Switzerland-based Occlutech Holding for…
Fortune Business Insights
Read More